cetirizine has been researched along with Inflammation in 12 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The CIRANO study suggests that levocetirizine is effective on PER symptoms, including a transient improvement in loss of smell, and that this improvement concurs more with reduction of nasal inflammation than of nasal patency." | 9.16 | The loss of smell in persistent allergic rhinitis is improved by levocetirizine due to reduction of nasal inflammation but not nasal congestion (the CIRANO study). ( Alobid, I; Bernal-Sprekelsen, M; Centellas, S; García-Piñero, A; Guilemany, JM; Mariño, FS; Mullol, J; Picado, C; Valero, A, 2012) |
| "Nasal obstruction is the main symptom in patients with perennial allergic rhinitis." | 6.71 | Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study. ( Allen, M; Barberi, S; Ciprandi, G; Cirillo, I; Civardi, E; Marseglia, GL; Vizzaccaro, A, 2005) |
| "The CIRANO study suggests that levocetirizine is effective on PER symptoms, including a transient improvement in loss of smell, and that this improvement concurs more with reduction of nasal inflammation than of nasal patency." | 5.16 | The loss of smell in persistent allergic rhinitis is improved by levocetirizine due to reduction of nasal inflammation but not nasal congestion (the CIRANO study). ( Alobid, I; Bernal-Sprekelsen, M; Centellas, S; García-Piñero, A; Guilemany, JM; Mariño, FS; Mullol, J; Picado, C; Valero, A, 2012) |
| "The present open label study in 62 patients indicates that levocetirizine 5 mg reliably controls persistent rhinitis over a period of 6 months, and shows a trend to be more effective in controlling the symptoms of rhinitis, improving QOL and decreasing nasal inflammation, when administered as long-term continuous therapy rather than as on-demand therapy." | 5.13 | Levocetirizine in persistent allergic rhinitis: continuous or on-demand use? A pilot study. ( Baiardini, I; Canonica, GW; Compalati, E; Fumagalli, F; Gamalero, C; Guerra, L; Massacane, P; Passalacqua, G; Riccio, AM; Rogkakou, A; Scordamaglia, A, 2008) |
| "The presented results indicate the effectiveness of theoritin and cetirizine in the treatment of patients with seasonal exacerbation of allergic rhinitis, comorbid for acute respiratory viral infections." | 4.12 | [Modern H1 antihistamines in the treatment of patients with allergic rhinitis and comorbid acute respiratory infections]. ( Miroshnichenko, NA; Nikolaeva, YO; Ovchinnikov, AY, 2022) |
| "Acute skin inflammation occurs following topical aminolevulinic acid-photodynamic therapy (ALA-PDT), but its nature and mediation are ill defined." | 3.73 | Histamine is released following aminolevulinic acid-photodynamic therapy of human skin and mediates an aminolevulinic acid dose-related immediate inflammatory response. ( Brooke, RC; Church, MK; Clough, GF; Friedmann, PS; Rhodes, LE; Sidhu, MK; Sinha, A; Watson, RE, 2006) |
| "Nasal obstruction is the main symptom in patients with perennial allergic rhinitis." | 2.71 | Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study. ( Allen, M; Barberi, S; Ciprandi, G; Cirillo, I; Civardi, E; Marseglia, GL; Vizzaccaro, A, 2005) |
| "Cetirizine treatment had no significant effect on these responses." | 2.68 | Cellular inflammatory responses during immediate, developing, and established late-phase allergic cutaneous reactions: effects of cetirizine. ( Atkins, PC; Ciliberti, M; Grossman, S; Moskovitz, A; von Allmen, C; Zweiman, B, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ovchinnikov, AY | 1 |
| Miroshnichenko, NA | 1 |
| Nikolaeva, YO | 1 |
| Bielory, L | 1 |
| Canonica, GW | 1 |
| Fumagalli, F | 1 |
| Guerra, L | 1 |
| Baiardini, I | 1 |
| Compalati, E | 1 |
| Rogkakou, A | 1 |
| Massacane, P | 1 |
| Gamalero, C | 1 |
| Riccio, AM | 1 |
| Scordamaglia, A | 1 |
| Passalacqua, G | 1 |
| Guilemany, JM | 1 |
| García-Piñero, A | 1 |
| Alobid, I | 1 |
| Centellas, S | 1 |
| Mariño, FS | 1 |
| Valero, A | 1 |
| Bernal-Sprekelsen, M | 1 |
| Picado, C | 1 |
| Mullol, J | 1 |
| Giustizieri, ML | 1 |
| Albanesi, C | 1 |
| Fluhr, J | 1 |
| Gisondi, P | 1 |
| Norgauer, J | 1 |
| Girolomoni, G | 1 |
| Ciprandi, G | 1 |
| Cirillo, I | 1 |
| Vizzaccaro, A | 1 |
| Civardi, E | 1 |
| Barberi, S | 1 |
| Allen, M | 1 |
| Marseglia, GL | 1 |
| Brooke, RC | 1 |
| Sinha, A | 1 |
| Sidhu, MK | 1 |
| Watson, RE | 1 |
| Church, MK | 1 |
| Friedmann, PS | 1 |
| Clough, GF | 1 |
| Rhodes, LE | 1 |
| Zweiman, B | 1 |
| Atkins, PC | 1 |
| Moskovitz, A | 1 |
| von Allmen, C | 1 |
| Ciliberti, M | 1 |
| Grossman, S | 1 |
| Hayashi, S | 1 |
| Hashimoto, S | 1 |
| Ollier, S | 1 |
| Varney, V | 1 |
| Gaga, M | 1 |
| Frew, AJ | 1 |
| De Vos, C | 1 |
| Kay, AB | 1 |
| Snyman, JR | 1 |
| Sommers, DK | 1 |
| Gregorowski, MD | 1 |
| Boraine, H | 1 |
6 trials available for cetirizine and Inflammation
| Article | Year |
|---|---|
Levocetirizine in persistent allergic rhinitis: continuous or on-demand use? A pilot study.
Topics: Adult; Aged; Cetirizine; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Inflammation; Male; | 2008 |
The loss of smell in persistent allergic rhinitis is improved by levocetirizine due to reduction of nasal inflammation but not nasal congestion (the CIRANO study).
Topics: Adult; Cetirizine; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Infl | 2012 |
Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.
Topics: Adolescent; Adult; Cetirizine; Double-Blind Method; Eosinophils; Female; Histamine H1 Antagonists, N | 2005 |
Cellular inflammatory responses during immediate, developing, and established late-phase allergic cutaneous reactions: effects of cetirizine.
Topics: Administration, Cutaneous; Anti-Allergic Agents; Biopsy; Blood Proteins; Cetirizine; Codeine; Eosino | 1997 |
The effect of a single oral dose of prednisolone or cetirizine on inflammatory cells infiltrating allergen-induced cutaneous late-phase reactions in atopic subjects.
Topics: Administration, Oral; Adolescent; Adult; Allergens; Cetirizine; Double-Blind Method; Histamine H1 An | 1992 |
Effect of cetirizine, ketotifen and chlorpheniramine on the dynamics of the cutaneous hypersensitivity reaction: a comparative study.
Topics: Basophils; Cetirizine; Chlorpheniramine; Dermatitis, Contact; Double-Blind Method; Eosinophils; Hist | 1992 |
6 other studies available for cetirizine and Inflammation
| Article | Year |
|---|---|
[Modern H1 antihistamines in the treatment of patients with allergic rhinitis and comorbid acute respiratory infections].
Topics: Adult; Cetirizine; Female; Histamine Antagonists; Histamine H1 Antagonists; Humans; Inflammation; Ma | 2022 |
Allergic inflammation of the anterior surface of the eye.
Topics: Adult; Cetirizine; Child; Conjunctivitis, Allergic; Eye; Histamine H1 Antagonists; Humans; Hypersens | 2020 |
H1 histamine receptor mediates inflammatory responses in human keratinocytes.
Topics: Adult; Cells, Cultured; Cetirizine; Chemokines; Female; Granulocyte-Macrophage Colony-Stimulating Fa | 2004 |
Histamine is released following aminolevulinic acid-photodynamic therapy of human skin and mediates an aminolevulinic acid dose-related immediate inflammatory response.
Topics: Adult; Aged; Aminolevulinic Acid; Cetirizine; Dose-Response Relationship, Drug; Erythema; Female; Hi | 2006 |
Anti-inflammatory actions of new antihistamines.
Topics: Anti-Inflammatory Agents; Cetirizine; Cytokines; Epithelial Cells; Histamine H1 Antagonists; Humans; | 1999 |
Cutaneous responses--a window on inflammatory processes.
Topics: Cetirizine; Histamine H1 Antagonists; Humans; Hydroxyzine; Hypersensitivity; Inflammation; Skin | 1992 |